Member Info for DJB67

Great interview today with Melissa, and definitely worth a listen. I’ll try posting the link but it’ll most likely get scrubbed by the LSE mods, but I’m sure folks can find it.

https://www.share-talk.com/zak-mir-talks-to-melissa-sturgess-ceo-ananda-developments/

Key points for me:
. Expect lots of progress in next 12 months
. With acquisition, all bases covered for UK patients
. Key milestone list albeit without dates, but next steps:
. Build of GMP1 facility
. ‘Pretty quick launch’ unlicensed oils (already in discussions with Pharmacies and clinicians re offtake agreements
. Things for shareholders to look out for:
. Progress on the GMP1 facility
. Signoff of flower manufacturing by MHRA (which enables Home Office granted research licence to be moved to a commercial licence)
. Launch of first products in the coming month (I heard month but could be a wording issue)

That interview answers a few questions I had, including does the fund raise just completed fully fund the GMP1 facility? I think we can say yes.
And when will we see first revenues? I think we can say this year.

All very positive!

Possibly, and the intertwined relationships between DP, Altair and others certainly doesn’t sit well.

But there is a 3rd option, and that is that the French govt required Eqt to confirm they were fully funded before they would commit €1m to the feasibility study.

Thanks djwall1s. As you say, LSE is a nightmare especially when it comes to posting links!

@Supplemental If you are after the ANA Telegram group, here is the link…Hopefully it will paste correctly and won’t be removed by mods.

*************anandadevelopmentsinvestorgroup

@wadogara. What is your comment about £7.5m clns?

That isn’t correct.

A max of 1.1bn clns were awarded to Charles Morgan as part of the loan debt conversion at the end of last year, but the RNS today states ‘ Mr Morgan has today converted all of the 2022 CLNs at a price of 0.3p per share, resulting in the issue to him of 747,264,000 new Ordinary Shares in aggregate (the “CLN Shares”). ’

There is nothing in the RNS today about £7.5m of clns.

@gazzleberry. There is a £100k broker option which allows existing shareholders to participate. You just need to contact either Ananda directly or Peterhouse who are running the raise.

RNS notifying withdrawal from Aquis

https://www.londonstockexchange.com/news-article/market-news/withdrawal-from-trading/15835448

What seriously hacks me off is the fact that Calamita seems to direct all responsibility for this disaster to the door of others, yet he has been CEO throughout! Does he still not realise that the buck stops with him!

An RNS is to be issued this afternoon, which should confirm the current position.

It’s not just poor corporate governance.

If we are to believe the Philip Small allegations it wi more a matter of fraud and criminal wrongdoings.

Sadly this is now confirmed by this statement on the Love Hemp website:

This text on lovehemp.com website

Paul Cooper and Jamie Taylor of Begbies Traynor were appointed Joint Administrators of Love Hemp Limited (“the Company”) on 9th February 2023. They are managing the affairs, business and property of the Company. The Company will continue to trade whilst the Joint Administrators carry out their statutory duties. All enquiries regarding the Administration process should be sent to lovehemp@btguk.com. The Joint Administrators act as agents of the Company and act without personal liability. Paul Cooper is licenced to act as an Insolvency Practitioner in the UK by the ICAEW and Jamie Taylor by the IPA.

RNS issued in response to the allegations thus weekend. In my opinion, it’s yet another own goal. A truly awful RNS, washing dirty laundry in public when what was required was a simple statement saying the board refutes all allegation and an investigation will commence.

Link here to anyone who hasn’t seen it.

https://www.londonstockexchange.com/news-article/market-news/board-response/15816347

If you have evidence of fraud then you should report it to the FCA and the SFO for investigation.

RNS

https://www.londonstockexchange.com/news-article/market-news/corporate-update/15765154

MD Philip Small was employed in a consultancy basis and was not a permanent employee, so probably just at the end of his contract.

It’s been confirmed in the LH Telegram group that TC has responded stating that this was a dormant company, never traded and the request to strike off is because there is no point in keeping it active.

@YorkshireMaek I’ve also seen the same explanation in the LH Telegram group from a shareholder who emailed TC.

My understanding was that LH Botanicals was setup for the white label business, which hasn’t really progressed. Looking at the Companies House entry shows the the last set of accounts posted in 2021 recorded only £1 in Assets., so basically a shell company waiting for something to happen. Looks to me like there is some tidying up going on.

In my opinion this is nothing to be concerned about.

Sought some clarification from Gerard today over Helium position given they were not listed as a major shareholder in the Final Report to 31/12 yet still listed on MSYS website.

Seems they are listed in the report under ISPartners Investment Solutions.

https://twitter.com/yorks_south/status/1535166158386651136?s=21&t=Mcb1GFoe8KfmUlJalnQ3gA

Liking this statement…. ????

Work has also progressed on both the actual submission to the Home Office for a commercial licence and planning for the larger footprint required for commercial cultivation.